Short stature: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 398: Line 398:


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
==Causes==
Shortness in children and young adults nearly always results from below-average [[Human development (biology)|growth]] in childhood, while shortness in older adults usually results from loss of height due to [[kyphosis]] of the [[vertebral column|spine]] or collapsed [[vertebra]]e from [[osteoporosis]].
From a medical perspective, severe shortness can be a [[human variability|variation]] of normal, resulting from the interplay of multiple familial genes. It can also be due to one or more of many abnormal conditions, such as chronic (prolonged) [[hormone]] deficiency, [[malnutrition]], disease of a major organ system, mistreatment, treatment with certain drugs, [[chromosome|chromosomal]] deletions, [[genetic disease|inherited diseases]],  [[birth defect]] [[syndrome]]s, bone structures fusing earlier than intended or many other causes.
HGH deficiency may occur at any time during infancy or childhood, with the most obvious sign being a noticeable slowing of growth. The deficiency may be genetic.
Increasing final height in children with short stature may be beneficial and could enhance HRQoL outcomes barring troublesome side effects and excessive cost of treatments.<ref name="urlHeight and Health-related Quality of Life">{{cite web |url=http://gghjournal.com/volume24/1/ab09.cfm |title=Height and Health-related Quality of Life |format= |work= |accessdate=}}</ref>
Disproportionate short stature
(Specific kind of Short stature) Shortcut to causes of Disproportionate short stature
Precocious puberty
(Specific kind of Short stature) Shortcut to causes of Precocious puberty
Proportionate short stature
(Specific kind of Short stature) Shortcut to causes of Proportionate short stature
Miscellaneous conditions
Malabsorption syndrome
Osteomalacia
Renal failure, chronic
Symptoms and signs
Hydrocephalus
Congenital conditions
Acrodermatitis enteropathica
Adiposogenital dystrophy
Beuren-Williams syndrome
Coffin syndrome 1
Combined pituitary hormone deficiency 5 (HESX1 gene)
Corpus callosum hypoplasia
Crome syndrome
Fallot tetralogy
Floating-Harbor syndrome
Hallermann-Streiff syndrome (HSS)
Hypothyroidism, congenital
Multiple pterygium syndrome
Nicolaides-Baraitser syndrome
Onat syndrome
Patent ductus arteriosus
Periodic hyperlysinemia
Russell-Silver dwarfism
Tricho-thiodystrophy
Xeroderma pigmentosum
Intrauterine acquired conditions
Intrauterine growth retardation
Chromosomal abnormalities
Brachydactyly-mental retardation syndrome
Chromosome 10q deletion syndrome
Chromosome 14 ring syndrome
Chromosome 15 ring syndrome
Chromosome 15q deletion syndrome
Chromosome 20 ring syndrome
Chromosome 4 ring syndrome
Chromosome 6 ring syndrome
Cri du chat syndrome 5p-
Deletion of short arm of chromosome 18
Down syndrome
Emanuel syndrome
Miller-Dieker syndrome
Prader-Willi syndrome
Smith-Magenis syndrome
Velocardiofacial syndrome
Wolf-Hirschhorn syndrome
XX male syndrome
Mendelian inherited conditions
Aspartylglucosaminuria
Bardet-Biedl syndrome
Beta thalassaemia (heterozygous)
Carbamoylphosphate synthetase deficiency
Complement 5 deficiency
Haemoglobin E disease
Hereditary sensorimotor neuropathy type 3
Kenny-Caffey-Linarelli syndrome
Leri-Weill dyschondrosteosis
Maple syrup urine disease
Nonbullous congenital ichthyosiform erythroderma
Say-Meyer syndrome
Sickle cell disease
Silver syndrome
Weill-Marchesani syndrome
Autosomal dominant conditions
4-hydroxyphenylpyruvate hydroxylase deficiency
Branchio-oculo-facial syndrome
CHARGE syndrome
Cleidocranial dysplasia
C-like syndrome
Hischsprung disease-microcephaly-mental retardation syndrome
Kabuki make-up syndrome
Lenz-Majewski hyperostosis syndrome
Multiple lentigines syndrome
Neurofibromatosis-Noonan syndrome
Osteogenesis imperfecta
Pitt-Hopkins syndrome
Pseudohypoaldosteronism type 1, autosomal dominant
Pseudohypoparathyroidism type 1a
Pseudopseudohypoparathyroidism
Rubinstein-Taybi syndrome
Tarsal-carpal coalition syndrome
Trichorhinophalangeal syndrome type 3
Trismus pseudocamptodactyly syndrome
Velocardiofacial syndrome
Weismann-Netter-Stuhl syndrome
Autosomal recessive conditions
3-Hydroxyisobutyric aciduria
3M syndrome
Aase syndrome
Abetalipoproteinaemia
Adenylosuccinate lyase deficiency
Alpha-L-iduronidase deficiency (Hurler syndrome)
Aminomethyltransferase deficiency
Arginine:glycine amidinotransferase deficiency
Aspartoacylase deficiency
ATP6V0A2-related cutis laxa
Baller-Gerold syndrome
Bartter syndrome
Bloom syndrome
Bonnet-Dechaume-Blanc syndrome
Bowen-Conradi syndrome
C21-hydroxylase deficiency
Carbamoylphosphate synthetase deficiency
Carbohydrate deficient glycoprotein syndrome type 1a
Carbonic anhydrase type 2 deficiency
Carey-Fineman-Ziter syndrome
CCFDN syndrome
Cholesterol ester storage disease
Chylomicron retention disease
Cockayne syndrome
Craniomandibular dermatodysostosis
Cystic fibrosis
Cystinosis
De Barsy syndrome
Desmosterolosis
D-glycerate kinase deficiency
Dibasic aminoaciduria type 2
Donohue syndrome
Ellis-van Creveld syndrome
Faciocardiorenal syndrome
Fanconi anaemia
Fibrochondrogenesis
Filippi syndrome
Fucosidosis
Galactosamine-6-sulfatase deficiency
Galactose epimerase deficiency
Galactosialidosis
Gangliosidosis GM1, type 1
Gangliosidosis GM2, type 1
Gaucher disease
Geleophysic dysplasia
Geroderma osteodysplastica
Glycine decarboxylase deficiency
Glycogenosis type 1a
GRACILE syndrome
Hereditary orotic aciduria
Hereditary sensory and autonomic neuropathy type 3
Hurst microtia-absent patellae-micrognathia syndrome
Hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome
Hyperostosis corticalis deformans juvenilis
Intestinal enteropeptidase deficiency
Isobutyryl-CoA dehydrogenase deficiency
Jeune thoracic dystrophy syndrome
Johanson-Blizzard syndrome
Kartagener syndrome
Majeed syndrome
Marden-Walker syndrome
Martsolf syndrome
Metaphyseal chondrodysplasia, McKusick type
Methylmalonic acidemia and homocystinuria, cblC type
Mevalonate kinase deficiency
Microcephaly, primary autosomal recessive, type 1
Mitochondrial DNA depletion syndrome, hepatocerebral form
Mucolipidosis II alpha/beta
Mucolipidosis III alpha/beta
Mucolipidosis III gamma
Mucopolysaccharidosis IX
Mucopolysaccharidosis VII
Nephropathic early-onset cystinosis
Neuhauser syndrome
Niemann-Pick disease type B
Nijmegen chromosome breakage syndrome
Opitz trigonocephaly syndrome
Pitt-Rogers-Danks syndrome
Progressive familial intrahepatic cholestasis type 1
Pseudohypoaldosteronism type 1, autosomal recessive
Pyknodysostosis
Ramon syndrome
RAPADILINO syndrome
S-adenosylhomocysteine hydrolase deficiency
Sanjad-Sakati syndrome
Schwartz-Jampel-Aberfeld syndrome
Short chain acyl-CoA dehydrogenase deficiency
SHORT syndrome
Succinyl-CoA synthetase deficiency
Systemic hyalinosis
Tyrosinaemia type 1
Werner syndrome
Yunis-Varon syndrome
X-linked inherited conditions
Aarskog syndrome
Atkin-Flaitz-Patil syndrome
Barth syndrome
BRESHECK syndrome
Coffin-Lowry syndrome
Creatine deficiency syndrome, X-linked
Dwarfism-cerebral atrophy-keratosis follicularis syndrome
Gangliosidosis GM3
Glycerol kinase deficiency
Iduronate-2-sulfatase deficiency
Menkes disease
Microphthalmia-dermal aplasia-sclerocornea syndrome
Opitz-Kaveggia syndrome
Ornithine carbamyltransferase deficiency
Otopalatodigital syndrome type 2
Pelizaeus-Merzbacher disease
Renpenning syndrome 1
X-linked hypophosphataemia
X-linked mental retardation-hypotonic facies syndrome
Young-Hughes syndrome
Mitochondrial genome inherited conditions
MELAS
Nutritional conditions
Kwashiorkor
Malabsorption syndrome
Marasmus
Autoimmune conditions
Diabetes mellitus type 1
Inflammatory conditions
Celiac disease
Neoplastic conditions
Histiocytosis X
Obstetric conditions
Intrauterine growth retardation
Premature labour and/or delivery
Respiratory conditions
Bronchial asthma
Bronchiectasis
Trauma, mechanical and physical conditions
Child abuse
Choledochal cyst
Sexual abuse
Infection and infective conditions
Tonsillitis
Urinary tract infection
Helminths and helminthic conditions
Ascariasis
Bacteria and bacterial conditions
Mycobacterium tuberculosis
Drug groups
Cytotoxic therapeutic agents
Drugs, hormones and mediators
Prednisolone
[[Ciclesonide]]
==Epidemiology and Demographics==
The American Association of Clinical Endocrinologists defines "short stature" as height more than 2 [[standard deviation]]s below the [[mean (statistics)|mean]] for age and gender, which corresponds to the shortest 2.3% of individuals.<ref name="urlFDA Approves Humatrope for Short Stature">{{cite web |url=http://www.fda.gov/bbs/topics/answers/2003/ans01242.html |title=FDA Approves Humatrope for Short Stature |publisher = [[U.S. Food and Drug Administration]] | date = 2003-07-25 |accessdate= 2009-01-13}} {{Dead link|date=October 2010|bot=H3llBot}}</ref>
==References==
{{Reflist|2}}
[[Category:Human height]]
[[Category:FLK]]
[[Category:Medical signs]]
[[Category:Symptoms]]
[[Category:Signs and symptoms]]
[[Category:Physical examination]]
{{WH}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Revision as of 08:11, 1 November 2020

Short stature
Classification and external resources
ICD-10 E34.3
ICD-9 783.43
DiseasesDB 18756
MedlinePlus 003271

WikiDoc Resources for Short stature

Articles

Most recent articles on Short stature

Most cited articles on Short stature

Review articles on Short stature

Articles on Short stature in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Short stature

Images of Short stature

Photos of Short stature

Podcasts & MP3s on Short stature

Videos on Short stature

Evidence Based Medicine

Cochrane Collaboration on Short stature

Bandolier on Short stature

TRIP on Short stature

Clinical Trials

Ongoing Trials on Short stature at Clinical Trials.gov

Trial results on Short stature

Clinical Trials on Short stature at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Short stature

NICE Guidance on Short stature

NHS PRODIGY Guidance

FDA on Short stature

CDC on Short stature

Books

Books on Short stature

News

Short stature in the news

Be alerted to news on Short stature

News trends on Short stature

Commentary

Blogs on Short stature

Definitions

Definitions of Short stature

Patient Resources / Community

Patient resources on Short stature

Discussion groups on Short stature

Patient Handouts on Short stature

Directions to Hospitals Treating Short stature

Risk calculators and risk factors for Short stature

Healthcare Provider Resources

Symptoms of Short stature

Causes & Risk Factors for Short stature

Diagnostic studies for Short stature

Treatment of Short stature

Continuing Medical Education (CME)

CME Programs on Short stature

International

Short stature en Espanol

Short stature en Francais

Business

Short stature in the Marketplace

Patents on Short stature

Experimental / Informatics

List of terms related to Short stature

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Short stature refers to a height of a human being which is below expected. Shortness is a vague term without a precise definition and with significant relativity to context. Because of the lack of preciseness, there is often disagreement about the degree of shortness that should be called short.

Historical Perspective

[Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event].

The association between [important risk factor/cause] and [disease name] was made in/during [year/event].

In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].

In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].

There have been several outbreaks of [disease name], including -----.

In [year], [diagnostic test/therapy] was developed by [scientist] to treat/diagnose [disease name].

Classification

There is no established system for the classification of short stature. Based on the etiology, short stature may be classified into normal variants of growth or systemic pathological causes. Normal variants of growth include- [1]

  • Familial short stature
  • Constitutional delay of growth and puberty
  • Small for gestational age with catch-up growth
  • Idiopathic short stature

For more information about the pathological etiology, refer to causes below.

Pathophysiology

The exact pathogenesis of [disease name] is not fully understood.

OR

It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].

OR

[Pathogen name] is usually transmitted via the [transmission route] route to the human host.

OR

Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.

OR


[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].

OR

The progression to [disease name] usually involves the [molecular pathway].

OR

The pathophysiology of [disease/malignancy] depends on the histological subtype.

Causes

Disease name] may be caused by [cause1], [cause2], or [cause3].

OR

Common causes of [disease] include [cause1], [cause2], and [cause3].

OR

The most common cause of [disease name] is [cause 1]. Less common causes of [disease name] include [cause 2], [cause 3], and [cause 4].

OR

The cause of [disease name] has not been identified. To review risk factors for the development of [disease name], click here.

Differentiating ((Page name)) from other Diseases

[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].

OR

[Disease name] must be differentiated from [[differential dx1], [differential dx2], and [differential dx3].

Epidemiology and Demographics

The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.

OR

In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.

OR

In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate of [number range]%.


Patients of all age groups may develop [disease name].

OR

The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.

OR

[Disease name] commonly affects individuals younger than/older than [number of years] years of age.

OR

[Chronic disease name] is usually first diagnosed among [age group].

OR

[Acute disease name] commonly affects [age group].


There is no racial predilection to [disease name].

OR

[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].


[Disease name] affects men and women equally.

OR

[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.


The majority of [disease name] cases are reported in [geographical region].

OR

[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

Risk Factors

There are no established risk factors for [disease name].

OR

The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].

OR

Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

OR

Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.

Screening

There is insufficient evidence to recommend routine screening for [disease/malignancy].

OR

According to the [guideline name], screening for [disease name] is not recommended.

OR

According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].

Natural History, Complications, and Prognosis

If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].

OR

Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].

OR

Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.

Diagnosis

Diagnostic Study of Choice

The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].

OR

The diagnosis of [disease name] is based on the [criteria name] criteria, which include [criterion 1], [criterion 2], and [criterion 3].

OR

The diagnosis of [disease name] is based on the [definition name] definition, which includes [criterion 1], [criterion 2], and [criterion 3].

OR

There are no established criteria for the diagnosis of [disease name].

History and Symptoms

The majority of patients with [disease name] are asymptomatic.

OR

The hallmark of [disease name] is [finding]. A positive history of [finding 1] and [finding 2] is suggestive of [disease name]. The most common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3]. Common symptoms of [disease] include [symptom 1], [symptom 2], and [symptom 3]. Less common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3].

Physical Examination

Patients with [disease name] usually appear [general appearance]. Physical examination of patients with [disease name] is usually remarkable for [finding 1], [finding 2], and [finding 3].

OR

Common physical examination findings of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

The presence of [finding(s)] on physical examination is diagnostic of [disease name].

OR

The presence of [finding(s)] on physical examination is highly suggestive of [disease name].

Laboratory Findings

An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].

OR

Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

OR

[Test] is usually normal among patients with [disease name].

OR

Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].

OR

There are no diagnostic laboratory findings associated with [disease name].

Electrocardiogram

There are no ECG findings associated with [disease name].

OR

An ECG may be helpful in the diagnosis of [disease name]. Findings on an ECG suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

X-ray

There are no x-ray findings associated with [disease name].

OR

An x-ray may be helpful in the diagnosis of [disease name]. Findings on an x-ray suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no x-ray findings associated with [disease name]. However, an x-ray may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

Echocardiography or Ultrasound

There are no echocardiography/ultrasound findings associated with [disease name].

OR

Echocardiography/ultrasound may be helpful in the diagnosis of [disease name]. Findings on an echocardiography/ultrasound suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no echocardiography/ultrasound findings associated with [disease name]. However, an echocardiography/ultrasound may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

CT scan

There are no CT scan findings associated with [disease name].

OR

[Location] CT scan may be helpful in the diagnosis of [disease name]. Findings on CT scan suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no CT scan findings associated with [disease name]. However, a CT scan may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

MRI

There are no MRI findings associated with [disease name].

OR

[Location] MRI may be helpful in the diagnosis of [disease name]. Findings on MRI suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no MRI findings associated with [disease name]. However, a MRI may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

Other Imaging Findings

There are no other imaging findings associated with [disease name].

OR

[Imaging modality] may be helpful in the diagnosis of [disease name]. Findings on an [imaging modality] suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies

There are no other diagnostic studies associated with [disease name].

OR

[Diagnostic study] may be helpful in the diagnosis of [disease name]. Findings suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

Other diagnostic studies for [disease name] include [diagnostic study 1], which demonstrates [finding 1], [finding 2], and [finding 3], and [diagnostic study 2], which demonstrates [finding 1], [finding 2], and [finding 3].

Treatment

Medical Therapy

There is no treatment for [disease name]; the mainstay of therapy is supportive care.

OR

Supportive therapy for [disease name] includes [therapy 1], [therapy 2], and [therapy 3].

OR

The majority of cases of [disease name] are self-limited and require only supportive care.

OR

[Disease name] is a medical emergency and requires prompt treatment.

OR

The mainstay of treatment for [disease name] is [therapy].

OR   The optimal therapy for [malignancy name] depends on the stage at diagnosis.

OR

[Therapy] is recommended among all patients who develop [disease name].

OR

Pharmacologic medical therapy is recommended among patients with [disease subclass 1], [disease subclass 2], and [disease subclass 3].

OR

Pharmacologic medical therapies for [disease name] include (either) [therapy 1], [therapy 2], and/or [therapy 3].

OR

Empiric therapy for [disease name] depends on [disease factor 1] and [disease factor 2].

OR

Patients with [disease subclass 1] are treated with [therapy 1], whereas patients with [disease subclass 2] are treated with [therapy 2].

Surgery

Surgical intervention is not recommended for the management of [disease name].

OR

Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]

OR

The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].

OR

The feasibility of surgery depends on the stage of [malignancy] at diagnosis.

OR

Surgery is the mainstay of treatment for [disease or malignancy].

Primary Prevention

There are no established measures for the primary prevention of [disease name].

OR

There are no available vaccines against [disease name].

OR

Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].

OR

[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].

Secondary Prevention

There are no established measures for the secondary prevention of [disease name].

OR

Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].

References

  1. Rogol AD, Hayden GF (2014). "Etiologies and early diagnosis of short stature and growth failure in children and adolescents". J Pediatr. 164 (5 Suppl): S1–14.e6. doi:10.1016/j.jpeds.2014.02.027. PMID 24731744.


Template:WikiDoc Sources